Particle.news
Download on the App Store
9 ARTICLES
·
12h ago

OpenAI Debuts GPT-Rosalind, a Biology Model for Early-Stage Research

OpenAI is testing the model with U.S. research groups under strict access rules to reduce biological misuse.

OpenAI logo is seen in this illustration taken May 20, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
A complex blue, glowing web of connections on a black background.
Image
Image

Overview

  • The research preview is available through ChatGPT, Codex, and the API for qualified U.S. customers in a trusted-access program, and usage during the preview does not count against credits for compliant users.
  • The model helps with evidence reviews, hypothesis generation, and experiment planning, and a free Life Sciences plugin for Codex links more than 50 tools and data sources.
  • OpenAI reports leading results on the BixBench bioinformatics test and top-tier performance with Dyno Therapeutics on an RNA sequence prediction task.
  • Early collaborators include Amgen, Moderna, the Allen Institute, Genentech, and Thermo Fisher Scientific on discovery workflows.
  • Access is limited to vetted research groups and monitored for bioweapons risks, and outside observers say the risk of hallucinated answers is not yet resolved.